Among the prognosis-related lncRNAs in HCC, SNHG3, SNHG4, and NRAV have been reported to function in bladder cancer (46), non-small cell lung cancer (47), osteosarcoma (48), colorectal cancer (49), breast cancer (50), gastric cancer (51), and glioma (52) through interactive molecular pathway studies. This evidence concerns the gene SNHG4 and breast cancer.